These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29228678)

  • 41. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells.
    Kang R; Zhao S; Liu L; Li F; Li E; Luo L; Xu L; Wan S; Zhao Z
    Cancer Cell Int; 2016; 16():20. PubMed ID: 26981049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to Regulate the Proliferation, Migration and Invasion of Prostate Cancer Cells Through the cGMP-PKG Signaling Pathway.
    Wang Z; Zhang C; Chang J; Tian X; Zhu C; Xu W
    Onco Targets Ther; 2020; 13():7045-7056. PubMed ID: 32801740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Forkhead Box S1 mediates epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway to regulate colorectal cancer progression.
    Zhang L; Ren CF; Yang Z; Gong LB; Wang C; Feng M; Guan WX
    J Transl Med; 2022 Jul; 20(1):327. PubMed ID: 35864528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PDLIM5 mediates PKCε translocation in PMA-induced growth cone collapse.
    Ren B; Li X; Zhang J; Fan J; Duan J; Chen Y
    Cell Signal; 2015 Mar; 27(3):424-35. PubMed ID: 25524223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
    Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
    Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.
    Gao Y; Teng J; Hong Y; Qu F; Ren J; Li L; Pan X; Chen L; Yin L; Xu D; Cui X
    Med Oncol; 2015 Jul; 32(7):518. PubMed ID: 26036682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells.
    Liu J; Lin F; Wang X; Li C; Qi Q
    Bioengineered; 2022 Apr; 13(4):7972-7983. PubMed ID: 35358005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.
    Zeng X; Hu Z; Wang Z; Tao J; Lu T; Yang C; Lee B; Ye Z
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):119-25. PubMed ID: 24418912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PDZRN4 suppresses tumorigenesis and androgen therapy-resistance in prostate cancer.
    Jin P; Wu L; Zhang G; Yang B; Zhu B
    J Cancer; 2022; 13(7):2293-2300. PubMed ID: 35517421
    [No Abstract]   [Full Text] [Related]  

  • 51. Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients.
    Cheng G; Wang S; Li X; Li S; Zheng Y; Zhang L; Bao M; Liang C; Huang Z; Liu Y; Qin C; Shao P; Li J; Hua L; Yin C; Wang Z
    Oncotarget; 2017 Sep; 8(38):64427-64439. PubMed ID: 28969082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
    Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
    Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ZNF24 is upregulated in prostate cancer and facilitates the epithelial-to-mesenchymal transition through the regulation of Twist1.
    Huang X; Liu N; Xiong X
    Oncol Lett; 2020 May; 19(5):3593-3601. PubMed ID: 32269634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.
    Chen M; Lv JM; Ye JQ; Cui XG; Qu FJ; Chen L; Liu X; Pan XW; Li L; Huang H; Yang QW; Chen J; Wang LH; Gao Y; Xu DF
    Int J Oncol; 2017 Jul; 51(1):39-48. PubMed ID: 28534961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MTSS1 hypermethylation is associated with prostate cancer progression.
    Chen J; Huang L; Zhu Q; Wang Z; Tang Z
    J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
    Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
    Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.
    Piao S; Zheng L; Zheng H; Zhou M; Feng Q; Zhou S; Ke M; Yang H; Wang X
    J Immunol Res; 2022; 2022():2922832. PubMed ID: 35707002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells.
    Huang Z; Li G; Zhang Z; Gu R; Wang W; Lai X; Cui ZK; Zeng F; Xu S; Deng F
    BMC Cancer; 2019 Nov; 19(1):1142. PubMed ID: 31771535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PPP5C promotes cell proliferation and survival in human prostate cancer by regulating of the JNK and ERK1/2 phosphorylation.
    Lv JM; Chen L; Gao Y; Huang H; Pan XW; Liu X; Chen M; Qu FJ; Li L; Wang JK; Cui XG; Xu DF
    Onco Targets Ther; 2018; 11():5797-5809. PubMed ID: 30254472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.